业界动态国内医卫资讯
免疫功能低下患者中的瑞德西韦：生存获益？
Medscape News · 2026-11-10 00:11
摘要
在住院的免疫系统减弱的患者中，一两天的用药时机差异似乎将分叉的生存曲线区分开来。近一半患者从未接受该药。Medscape Medical News
English
Remdesivir in Immunocompromised Patients: Survival Benefit?
Among hospitalized patients with weakened immune systems, a single day or two of timing appeared to separate diverging survival curves. Nearly half never received the drug at all. Medscape Medical News